Showing results (141-150 of 224) with videos related to

Sort By:
Pageof 23
Acta Gastro-Enterologica Belgica|May 1, 2009
The antiproliferative effect of somatostatin analogs: clinical relevance in patients with neuroendocrine gastro-entero-pancreatic tumoursC Verslype, S Carton, I Borbath, et al.
ESMO Open|December 1, 2022
Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancerE Van Cutsem, H Hochster, K Shitara, et al.
Acta Gastro-Enterologica Belgica|May 1, 2009
The potential role of targeted therapies in the management of neuroendocrine tumoursG Verset, I Borbath, T Delaunoit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2019
Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studiesJ Taieb, Q Shi, L Pederson, et al.
British Journal of Cancer|June 13, 2015
Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesisL De Smedt, J Lemahieu, S Palmans, et al.
Cancer Treatment Reviews|December 24, 2014
Optimising translational oncology in clinical practice: strategies to accelerate progress in drug developmentR Stahel, J Bogaerts, F Ciardiello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancerS Siena, A Sartore-Bianchi, R Garcia-Carbonero, et al.
Acta Gastro-Enterologica Belgica|May 1, 2009
Role of chemotherapy in gastro-entero-pancreatic neuroendocrine tumors: the end of a story?T Delaunoit, M Van den Eynde, I Borbath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinomaP Flamen, A Lerut, E Van Cutsem, et al.
ESMO Open|August 9, 2021
Quality of life with first-line pembrolizumab for PD-L1-positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 studyE Van Cutsem, A Valderrama, Y-J Bang, et al.
Pageof 23